ÇѸ²´ëÇб³¼º½Éº´¿ø

½Åµ¿¿ì ±³¼ö

  • Áø·á°ú ¼ÒÈ­±â³»°ú

Àü¹®Áø·áºÐ¾ß

ÃéÀå´ãµµ Áúȯ

ÀüÈ­ ¿¹¾à 1577-1801
±³¼ö´Ô»çÁø

(ÁÖ°£) Áø·á½Ã°£Ç¥ (2024-05-20 ~ 2024-05-25)

Áø·á½Ã°£Ç¥
Áø·á½Ã°£ ¿ù È­ ¼ö ¸ñ ±Ý Åä
¿ÀÀü ¼¾ÅÍÁø·á¼¾ÅÍÁø·á¼¾ÅÍÁø·á
¿ÀÈÄ ¼¾ÅÍÁø·á¼¾ÅÍÁø·á
±³¼ö´Ô »çÁø

±âº»Á¤º¸

ÇзÂ

ÇзÂ

2018.09 ~ 2020.08¼­¿ï´ëÇб³ ´ëÇпø ¹Ú»ç ¼ö·á

2014.09 ~ 2016.08°æºÏ´ëÇб³ ´ëÇпø ¼®»ç

2003.03 ~ 2009.02Á¦ÁÖ´ëÇб³ ÀÇ°ú´ëÇÐ Çлç

°æ·Â

°æ·Â

2022.03 ~ ÇѸ²´ëÇб³¼º½Éº´¿ø ¼ÒÈ­±â³»°ú Á¶±³¼ö

2020.01 ~ 2022.02°è¸í´ëÇб³ µ¿»êº´¿ø ¼ÒÈ­±â³»°ú Á¶±³¼ö

2019.03 ~ 2019.12ºÐ´ç¼­¿ï´ëÇб³º´¿ø ¼ÒÈ­±â³»°ú Áø·áÀü¹®ÀÇ

2017.05 ~ 2019.02ºÐ´ç¼­¿ï´ëÇб³º´¿ø ¼ÒÈ­±â³»°ú ÀÓ»ó°­»ç

2014.04 ~ 2017.04º´¹«Ã» Áß¾Ó½Åü°Ë»ç¼Ò º´¿ªÆÇÁ¤°Ë»çÀü´ãÀÇ»ç

ÇÐȸȰµ¿

ÇÐȸȰµ¿

2024.03 ~ ´ëÇѼÒÈ­±âÇÐȸ Æò»ýȸ¿ø, ÆíÁýÀ§¿øȸ/ÇмúÀ§¿øȸ À§¿ø

2023.03 ~ ´ëÇÑÀÇ·á±â¼úÇõ½ÅÇÐȸ ÆíÁýÀ§¿øȸ À§¿ø

2018.08 ~ ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ Á¤È¸¿ø, ³»½Ã°æ ¼¼ºÎÀü¹®ÀÇ, ±³À°¼ö·ÃÀ§¿øȸ À§¿ø

2018.07 ~ ´ëÇѼÒÈ­±â¾ÏÇÐȸ Æò»ýȸ¿ø, ¼ÒÈ­±â¾Ï ÀÎÁ¤ÀÇ, ÃéÀå´ãµµ¾ÏÀ§¿øȸ/ÇмúÀ§¿øȸ À§¿ø

2018.04 ~ ´ëÇÑÃéÀå´ãµµÇÐȸ Æò»ýȸ¿ø, ÃéÀå´ãµµ³»½Ã°æ(ERCP) ÀÎÁõÀÇ/ÁöµµÀü¹®ÀÇ, Á¤º¸À§¿øȸ/º¸ÇèÀ§¿øȸ À§¿ø

2014.02 ~ ´ëÇѳ»°úÇÐȸ Á¤È¸¿ø, ¼ÒÈ­±â³»°ú ºÐ°úÀü¹®ÀÇ

¼ö»óÀÌ·Â

¼ö»óÀÌ·Â

2022.04Seoul International Digestive Disease Symposium (SIDDS) 2022 ¿ì¼ö¿¬±¸»ó

2020.08´ëÇÑÃéÀå´ãµµÇÐȸ(IC-KBPA 2020) ¿ì¼ö±¸¿¬»ó

2019.09´ëÇÑÃéÀå´ãµµÇÐȸ Ãß°èÇмú´ëȸ ¿ì¼öÆ÷½ºÅÍ»ó

2018.11´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ¿ì¼ö³í¹®»ó

³í¹®

Shin DW, Lee JM, Lee JC, Lee HS, Yoon SB, Jang DK, et al. Adjuvant Chemotherapy and Effect on Long-Term Survival in Ampullary Adenocarcinoma: A Multicenter Cohort Study. J Am Coll Surg. 2023;237(3):501-12.

Shin DW, Moon SH, Kim JH. Diagnosis of Cholangiocarcinoma. Diagnostics (Basel). 2023 Jan 8;13(2):233.

Shin DW, Park J, Lee JC, Kim J, Kim YH, Hwang JH. Multi-Phase, Contrast-Enhanced Computed Tomography-Based Radiomic Prognostic Marker of Non-Metastatic Pancreatic Ductal Adenocarcinoma. Cancers (Basel). 2022 May 18;14(10):2476.

Shin DW, Kim S, Jung K, Jung JH, Kim B, Ahn J, et al. Impact of histopathological type on the prognosis of ampullary carcinoma: A systematic review and meta-analysis. Eur J Surg Oncol. 2023 Feb;49(2):306-315.

Shin DW, Lee JC, Kim J, Yoon YS, Han HS, Kim H, et al. Tailored adjuvant gemcitabine versus 5-fluorouracil/folinic acid based on hENT1 immunohistochemical staining in resected pancreatic ductal adenocarcinoma: A biomarker stratified prospective trial. Pancreatology. 2021;21(4):796-804.

Shin DW, Kim MJ, Lee JC, Kim J, Woo SM, Lee WJ, et al. Gemcitabine Plus Cisplatin Chemotherapy Prolongs the Survival in Advanced Hilar Cholangiocarcinoma: A Large Multicenter Study. Am J Clin Oncol. 2020;43(6):422-7.

Shin DW, Lee JC, Kim J, Woo SM, Lee WJ, Han SS, et al. Validation of the American Joint Committee on Cancer 8th edition staging system for the pancreatic ductal adenocarcinoma. Eur J Surg Oncol. 2019;45(11):2159-65.

Shin DW, Kim J. The American Joint Committee on Cancer 8th edition staging system for the pancreatic ductal adenocarcinoma: is it better than the 7th edition? Hepatobiliary Surg Nutr. 2020;9(1):98-100.

Shin DW, Choi YJ, Kim HS, Han KD, Yoon H, Park YS, et al. Secondary Breast, Ovarian, and Uterine Cancers After Colorectal Cancer: A Nationwide Population-Based Cohort Study in Korea. Dis Colon Rectum. 2018;61(11):1250-7.

Shin DW, Yoon H, Kim HS, Choi YJ, Shin CM, Park YS, et al. Effects of Alkaline-Reduced Drinking Water on Irritable Bowel Syndrome with Diarrhea: A Randomized Double-Blind, Placebo-Controlled Pilot Study. Evid Based Complement Alternat Med. 2018;2018:9147914.

Shin DW, Hwang HY, Jeon SW. Comparison of Endoscopic Submucosal Dissection and Surgery for Differentiated Type Early Gastric Cancer within the Expanded Criteria. Clin Endosc. 2017;50(2):170-8.

Shin DW, Kim MA, Lee JC, Kim J, Hwang JH. Maintenance of skeletal muscle mass during FOLFIRINOX is a favorable prognostic factor in pancreatic cancer patients. BMC Res Notes. 2021;14(1):272.

Shin DW. Treatment of Ampullary Adenocarcinoma. Korean J Gastroenterol. 2023;82(4):159-70.

Bae J, Shin DW, Cho KB, Ahn KS, Kim TS, Kim YH, et al. Survival outcome of surgical resection compared to non-resection for Bismuth type IV perihilar cholangiocarcinoma. Langenbecks Arch Surg. 2023;408(1):229.

Jang DK, Kim SJ, Chung HH, Lee JM, Yoon SB, Lee JC, et al. Outcomes of Palliative Chemotherapy for Ampulla of Vater Adenocarcinoma: A Multicenter Cohort Study. Gut Liver. 2023.

Yoon SB, Jeon TY, Moon SH, Shin DW, Park JW, Kim SE, et al. Effectiveness and complication rates of percutaneous transhepatic fluoroscopy-guided management of common bile duct stones: a single-arm meta-analysis. Eur Radiol. 2023;33(11):7398-407.

Yoon SB, Yang MJ, Shin DW, Soh JS, Lim H, Kang HS, et al. Endoscopic ultrasound-rendezvous versus percutaneous-endoscopic rendezvous endoscopic retrograde cholangiopancreatography for bile duct access: Systematic review and meta-analysis. Dig Endosc. 2023.

Yoo JW, Jo SI, Shin DW, Park JW, Kim SE, Lim H, et al. Clinical Usefulness of Immune Profiling for Differential Diagnosis between Crohn's Disease, Intestinal Tuberculosis, and Behcet's Disease. Diagnostics (Basel). 2023 Sep 11;13(18):2904.

Yoon SB, Jeon TY, Moon SH, Shin DW, Lee SM, Choi MH, et al. Differentiation of autoimmune pancreatitis from pancreatic adenocarcinoma using CT characteristics: a systematic review and meta-analysis. Eur Radiol. 2023;33(12):9010-21.

Hwang YJ, Shin DW, Kim N, Yoon H, Shin CM, Park YS, et al. Sex difference in bowel preparation quality and colonoscopy time. Korean J Intern Med. 2021;36(2):322-31.

Yoon SB, Jung MK, Lee YS, Park JK, Jang DK, Lee JM, Lee HS, Shin DW, Lee JC, Hwang JH. Long-term outcomes of endoscopic papillectomy for ampullary adenoma with high-grade dysplasia or adenocarcinoma: a propensity score-matched analysis. Surg Endosc. 2023 May;37(5):3522-3530.

Park M, Lee JW, Shin DW, Kim J, Lee YJ, Lee JY, et al. Comparison between a novel core knife and the conventional IT knife 2 for endoscopic submucosal dissection of gastric mucosal lesions. Clin Endosc. 2022;55(6):767-74.

Han SY, Kim DU, Nam HS, Kang DH, Jang SI, Lee DK, Shin DW et al. Comparison of the Malignant Predictors in Intrahepatic and Extrahepatic Intraductal Papillary Neoplasm of the Bile Duct. J Clin Med. 2022 Apr 2;11(7):1985.

Han JY, Ahn KS, Kim TS, Kim YH, Cho KB, Shin DW, et al. Liquid Biopsy from Bile-Circulating Tumor DNA in Patients with Biliary Tract Cancer. Cancers (Basel). 2021 Sep 12;13(18):4581.

Lee JC, Woo SM, Shin DW, Kim J, Yang SY, Kim MJ, et al. Comparison of FOLFIRINOX and Gemcitabine Plus Nab-paclitaxel for Treatment of Metastatic Pancreatic Cancer: Using Korean Pancreatic Cancer (K-PaC) Registry. Am J Clin Oncol. 2020;43(9):654-9.

Lee JC, Shin DW, Park H, Kim J, Youn Y, Kim JH, et al. Tolerability and safety of EUS-injected adenovirus-mediated double-suicide gene therapy with chemotherapy in locally advanced pancreatic cancer: a phase 1 trial. Gastrointest Endosc. 2020;92(5):1044-52.e1.

Cho JH, Yoon YS, Kim EJ, Kim YS, Cho JY, Han HS, Park YH, Shin DW, Lee JC, Hwang JH, Kim J. A multicenter prospective randomized controlled trial for preoperative biliary drainage with uncovered metal versus plastic stents for resectable periampullary cancer. J Hepatobiliary Pancreat Sci. 2020;27(10):690-9.

Ahn S, Lee JC, Shin DW, Kim J, Hwang JH. High PD-L1 expression is associated with therapeutic response to pembrolizumab in patients with advanced biliary tract cancer. Sci Rep. 2020;10(1):12348.

Choi YJ, Lee DH, Shin DW, Han KD, Yoon H, Shin CM, et al. Patients with inflammatory bowel disease have an increased risk of myocardial infarction: a nationwide study. Aliment Pharmacol Ther. 2019;50(7):769-79.

Song DH, Cho IK, Shin DW, Lee JC, Cho JY, Yoon YS, et al. The clinical significance of preoperative C-reactive protein/albumin ratio in patients with resected extrahepatic bile duct cancer. Surg Today. 2021;51(6):978-85.

Kim HS, Choi YJ, Shin DW, Han KD, Yoon H, Shin CM, et al. Secondary Primary Prostate Cancer after Colorectal Cancer: A Nationwide Population-based Cohort Study in Korea. J Cancer Prev. 2017;22(4):241-7.

Jung JH, Shin DW, Kim J, Lee JC, Hwang JH. Primary Granulocyte Colony-Stimulating Factor Prophylaxis in Metastatic Pancreatic Cancer Patients Treated with FOLFIRINOX as the First-Line Treatment. Cancers (Basel). 2020;12(11).

Kim HS, Yoon H, Shin DW, Oh DJ, Kwon M, Choi YJ, Shin CM, Park YS, Kim N, Lee DH Efficacy of and Resistance to Rifaximin-based Quadruple Therapy in Helicobacter pylori Eradication. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2020;20(3):218-224.